• 1. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 2. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 3. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 4. Alumina coating on 5 V lithium cobalt fluorophosphate cathode material for lithium secondary batteries – synthesis and electrochemical properties?
  S. Amaresh,K. Karthikeyan,K. J. Kim,Y. S. Lee RSC Adv., 2014,4, 23107-23115
• 5. An investigation of surface properties, local elastic modulus and interaction with simulated pulmonary surfactant of surface modified inhalable voriconazole dry powders using atomic force microscopy
  Michael Kappl,Paul M. Young,Daniela Traini,Sanyog Jain RSC Adv., 2016,6, 25789-25798

Recent Advances in the Study of Phenol, 4,4'-(1,2-diphenyl-1,2-ethenediyl)bis- (CAS 68578-79-0)

Phenol, 4,4'-(1,2-diphenyl-1,2-ethenediyl)bis-, commonly referred to by its CAS number 68578-79-0, is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. This compound, characterized by its unique stilbene-based structure, has been the subject of numerous studies due to its potential applications in drug development, material science, and molecular imaging. Recent research has focused on elucidating its pharmacological properties, synthetic pathways, and potential therapeutic uses, making it a compound of high relevance in contemporary scientific inquiry.

One of the most notable advancements in the study of 68578-79-0 is its role as a fluorescent probe in biological imaging. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibit strong fluorescence properties, making them suitable for tracking cellular processes in real-time. The study highlighted the compound's stability and low cytotoxicity, which are critical for in vivo applications. Researchers utilized advanced spectroscopic techniques to characterize the fluorescence emission spectra, revealing a peak at 450 nm, which is optimal for bioimaging applications.

In addition to its imaging capabilities, 68578-79-0 has shown promise as a scaffold for the development of novel therapeutics. A recent preprint on bioRxiv detailed the synthesis of a series of analogs derived from this compound, which were screened for anti-inflammatory activity. The results indicated that certain analogs exhibited potent inhibition of NF-κB signaling, a key pathway in inflammatory diseases. Molecular docking studies further suggested that these analogs bind to the p65 subunit of NF-κB, providing a mechanistic basis for their activity. These findings open new avenues for the design of anti-inflammatory drugs targeting this pathway.

The synthetic chemistry of 68578-79-0 has also seen significant progress. A 2024 publication in Organic Letters reported a novel, high-yield synthesis route for this compound using a palladium-catalyzed cross-coupling reaction. This method offers several advantages over traditional approaches, including reduced reaction times and higher purity of the final product. The authors also explored the scalability of this method, demonstrating its potential for industrial-scale production. Such advancements are crucial for ensuring the availability of this compound for further research and development.

Despite these promising developments, challenges remain in the application of 68578-79-0. For instance, its poor solubility in aqueous media limits its bioavailability, a common issue for hydrophobic compounds. Recent efforts to address this include the development of nanoparticle-based delivery systems. A study in ACS Nano described the encapsulation of 68578-79-0 in polymeric nanoparticles, which significantly improved its solubility and cellular uptake. This approach not only enhances the compound's therapeutic potential but also provides a model for the delivery of similar hydrophobic agents.

In conclusion, Phenol, 4,4'-(1,2-diphenyl-1,2-ethenediyl)bis- (CAS 68578-79-0) continues to be a compound of great interest in chemical biology and pharmaceutical research. Recent studies have expanded our understanding of its applications in bioimaging, drug development, and synthetic chemistry. While challenges such as solubility persist, innovative solutions like nanoparticle delivery systems are paving the way for its broader use. Future research will likely focus on further optimizing its properties and exploring new therapeutic targets, solidifying its place in the toolkit of modern medicinal chemistry.

• 66422-18-2(1,1-bis(4-hydroxyphenyl)-2-phenylethylene)
• 919789-89-2(Phenol, 4-(1-methyl-2-phenyl-1-propen-1-yl)-)
• 61064-71-9(Phenol, 4,4'-(1-phenyl-1,2-ethenediyl)bis[2,6-dimethyl-)
• 13366-36-4(Phenol,4,4'-(1,2-dimethyl-1,2-ethenediyl)bis-)
• 61064-72-0(Phenol, 4,4'-(phenylethenylidene)bis[2,6-dimethyl-)
• 919789-82-5(Phenol, 4-(1-methyl-2,2-diphenylethenyl)-)
• 82925-28-8((Z,E)-1,2-DIPHENYL-1-(4-HYDROXYPHENYL)ETHENE)
• 552-80-7(Phenol,4,4'-[(1E)-1,2-dimethyl-1,2-ethenediyl]bis-)
• 76115-06-5(4-(1,2,2-Triphenylvinyl)phenol)
• 919789-77-8(DHTPE)